Effectiveness of laser coagulation in children with Coats’ disease
- Authors: Demchenko E.N.1, Denisova E.V.1, Kogoleva L.V.1, Belova M.V.1, Osipova N.A.1
-
Affiliations:
- Helmholtz National Medical Research Center of Eye Diseases
- Issue: Vol 17, No 3 (2022)
- Pages: 5-13
- Section: Original study article
- URL: https://journal-vniispk.ru/1993-1859/article/view/108456
- DOI: https://doi.org/10.17816/rpoj108456
- ID: 108456
Cite item
Abstract
AIM: This study aimed to investigate the effectiveness of retinal laser coagulation in children with Coats’ disease.
MATERIAL AND METHODS: The study included 118 patients who were examined and treated from January 2017 to December 2021; 102 of them were boys (86.6%) and 16 were girls (13.4%). All children had unilateral disease. All children underwent a comprehensive ophthalmological examination. Laser coagulation was performed in 113 patients using a green laser (532 nm). The number of retinal laser coagulation sessions ranged from 2 to 13 (on average 5.2±2.36) with intervals from 1.5 to 6 months (on average 2.01±0.46).
RESULTS: Generally, retinal laser coagulation was effective in CD in 85.8% of cases (in 97 of 113 children). Effectiveness was 100% for vascular malformations and exudates outside the macula, 97.3% for vascular and exudative retinal changes involving the macular zone, 92.3% for local retinal detachment, 90.5% for widespread retinal detachment, 60.0% for subtotal retinal detachment, and 30.0% for total. Only those who had peripheral Coats’ disease symptoms were found to have visual acuity of 0.6 or above, both before and after treatment. Visual acuity did not exceed 0.1 in 92% of patients with vascular and exudative changes in the periphery and in the macula and in 94% with local and widespread retinal detachment. After successful retinal laser coagulation, 11 children (13.4%) had visual acuity of 0.4 or higher, 13 children (15.9%) had visual acuity between 0.1 and 0.3, 45 children (54.9%) had finger count of 0.09, and 13 children (15.9%) lack objective vision.
CONCLUSION: Retinal laser coagulation using a laser with a wavelength of 532 nm is an effective method for treating CD at all stages, including cases of the disease with the development of retinal detachment.
Full Text
##article.viewOnOriginalSite##About the authors
Elena N. Demchenko
Helmholtz National Medical Research Center of Eye Diseases
Author for correspondence.
Email: ddddemchenko@yandex.ru
ORCID iD: 0000-0001-6523-5191
MD, Cand. Sci. (Med.)
Russian Federation, MoscowEkaterina V. Denisova
Helmholtz National Medical Research Center of Eye Diseases
Email: deale_2006@inbox.ru
ORCID iD: 0000-0003-3735-6249
SPIN-code: 4111-4330
MD, Cand. Sci. (Med.)
Russian Federation, MoscowLudmila V. Kogoleva
Helmholtz National Medical Research Center of Eye Diseases
Email: kogoleva@mail.ru
ORCID iD: 0000-0002-2768-0443
MD, Dr. Sci. (Med.)
Russian Federation, MoscowMarya V. Belova
Helmholtz National Medical Research Center of Eye Diseases
Email: mbelova.doc@gmail.rcom
ORCID iD: 0000-0001-6465-2313
MD, Cand. Sci. (Med.)
Russian Federation, MoscowNatalya A. Osipova
Helmholtz National Medical Research Center of Eye Diseases
Email: natashamma@mail.ru
ORCID iD: 0000-0002-3151-6910
SPIN-code: 5872-6819
MD, Cand. Sci. (Med.)
Russian Federation, MoscowReferences
- Coats G. Forms of retinal dysplasia with massive exudation. R Lond Ophthalmol Hosp Rep. 1908;17:440–525.
- Shields JA, Shields CL, Honavar SG, Demirci H. Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture. Am J Ophthalmol. 2001;131(5):561–571. doi: 10.1016/s0002-9394(00)00883-7
- Fernandes BF, Odashiro AN, Maloney S, et al. Clinical-histopathological correlation in a case of Coats’ disease. Diagn Pathol. 2006;1:24. doi: 10.1186/1746-1596-1-24
- He YG, Wang H, Zhao B, et al. Elevated vascular endothelial growth factor level in Coats’ disease and possible therapeutic role of bevacizumab. Graefes Arch Clin Exp Ophthalmol. 2010;248(10):1519–1521. doi: 10.1007/s00417-010-1366-1
- Katsnel’son LA, Forofonova TI, Bunin AYa. Vascular eye diseases. Moskva: Meditsina; 1990. (In Russ).
- Sen M, Shields CL, Honavar SG, Shields JA. Coats disease: An overview of classification, management and outcomes. Indian J Ophthalmol. 2019;67(6):763–771. doi: 10.4103/ijo.IJO_841_19
- Dalvin LA, Udyaver S, Lim LS, et al. Coats Disease: Clinical Features and Outcomes by Age Category in 351 Cases. J Pediatr Ophthalmol Strabismus. 2019;56(5):288–296. doi: 10.3928/01913913-20190716-01
- Shields CL, Udyaver S, Dalvin LA, et al. Coats disease in 351 eyes: Analysis of features and outcomes over 45 years (by decade) at a single center. Indian J Ophthalmol. 2019;67(6):772–783. doi: 10.4103/ijo.IJO_449_19
- Lanier JD, McCrary JA, 3rd, Justice J. Autosomal recessive retinitis pigmentosa and Coats disease: a presumed familial incidence. Arch Ophthalmol. 1976;94(10):1737–1742. doi: 10.1001/archopht.1976.03910040511009
- Frezzotti R, Berengo A, Guerra R, Cavalllini F. Toxoplasmic Coats’ Retinitis. A Parasitologically Proved Case. Am J Ophthalmol. 1965;59:1099–1102.
- Small RG. Coats’ disease and muscular dystrophy. Trans Am Acad Ophthalmol Otolaryngol. 1968;72(2):225–231.
- Folk JC, Genovese FN, Biglan AW. Coats’ disease in a patient with Cornelia de Lange syndrome. Am J Ophthalmol. 1981;91(5):607–610. doi: 10.1016/0002-9394(81)90059-3
- Denisova EV, Katargina LA, Kogoleva LV, et al. Eye pathologies in facioscapulohumeral muscular dystrophy (case report and literary analysis). Russian Ophthalmological Journal. 2018;11(3):50–54. (In Russ). doi: 10.21516/2072-0076-2018-11-3-50-54
- Li S, Deng G, Liu J, et al. The effects of a treatment combination of anti-VEGF injections, laser coagulation and cryotherapy on patients with type 3 Coat’s disease. BMC Ophthalmol. 2017;17(1):76. doi: 10.1186/s12886-017-0469-4
- Shapiro MJ, Chow CC, Karth PA, et al. Effects of green diode laser in the treatment of pediatric Coats disease. Am J Ophthalmol. 2011;151(4):725–731 e722. doi: 10.1016/j.ajo.2010.10.024
- Schefler AC, Berrocal AM, Murray TG. Advanced Coats’ disease. Management with repetitive aggressive laser ablation therapy. Retina. 2008;28(3 Suppl):S38–41. doi: 10.1097/IAE.0b013e318163cd7c
- Levinson JD, Hubbard GB, 3rd. 577-Nm Yellow Laser Photocoagulation for Coats Disease. Retina. 2016;36(7):1388–1394. doi: 10.1097/IAE.0000000000000874
Supplementary files
